Valuation : Devyser Diagnostics AB

Market Cap 941M 97.09M 83.65M 79.21M 71.8M 135M 9.28B 135M 362M 4.72B 365M 357M 14.91B P/E 2026 *
91.9x
P/E 2027 * 28.8x
Enterprise Value 894M 92.24M 79.47M 75.25M 68.21M 128M 8.81B 129M 344M 4.48B 346M 339M 14.17B EV / Sales 2026 *
3.63x
EV / Sales 2027 * 3.03x
Free-Float
70.22%
Yield 2026 *
-
Yield 2027 * -
1 day-1.94%
1 week-7.01%
Current month-4.95%
1 month-9.58%
3 months-37.90%
6 months-34.24%
Current year-51.23%
1 week 55.2
Extreme 55.2
61.1
1 month 55.2
Extreme 55.2
66.8
Current year 55.2
Extreme 55.2
114.8
1 year 55.2
Extreme 55.2
159.6
3 years 55.2
Extreme 55.2
159.6
5 years 55.2
Extreme 55.2
159.6
10 years 55.2
Extreme 55.2
159.6
Manager TitleAgeSince
Chief Executive Officer 59 2025-08-03
Director of Finance/CFO 43 2020-12-31
Chief Tech/Sci/R&D Officer 48 2024-01-31
Director TitleAgeSince
Chairman 57 2021-05-26
Director/Board Member 49 2020-12-31
Director/Board Member 72 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/3/26 Buy

Director

2,000 0.0120%
8/25/26 Buy

Director

568 0.0034%
8/11/26 Buy

Director

5,000 0.0300%
Change 5-day change 1-year change 3-year change Capi.($)
-1.94%-7.01%-62.47%-22.64% 97.09M
-0.71%-6.35%-2.99%+9.59% 45.48B
+0.21%-2.98%+337.74%+519.55% 43.68B
+1.74%-2.24%+39.82%+20.76% 43.09B
+1.38%-3.28%+6.84%+67.62% 39.4B
-1.44%-5.26%+8.97%+39.76% 31.91B
+0.87%-2.60% - - 17.31B
+0.75%-0.64%+19.75%+110.17% 16.4B
-0.31%-2.78%+10.78%+31.02% 14.24B
+1.93%-3.55%+82.00%+41.17% 13.28B
Average +0.25%-3.92%+48.94%+90.78% 26.49B
Weighted average by Cap. +0.41%-3.67%+74.51%+124.20%

Financials

2026 *2027 *
Net sales 246M 25.38M 21.87M 20.71M 18.77M 35.21M 2.42B 35.39M 94.58M 1.23B 95.33M 93.24M 3.9B 298M 30.71M 26.46M 25.05M 22.71M 42.6M 2.93B 42.82M 114M 1.49B 115M 113M 4.72B
Net income 10.07M 1.04M 895K 848K 768K 1.44M 99.25M 1.45M 3.87M 50.49M 3.9M 3.82M 160M 31.97M 3.3M 2.84M 2.69M 2.44M 4.58M 315M 4.6M 12.3M 160M 12.39M 12.12M 507M
Net Debt -47.04M -4.86M -4.18M -3.96M -3.59M -6.74M -464M -6.77M -18.09M -236M -18.23M -17.83M -746M -39M -4.02M -3.47M -3.28M -2.98M -5.58M -385M -5.61M -15M -196M -15.12M -14.78M -618M
Logo Devyser Diagnostics AB
Devyser Diagnostics AB is a Sweden-based company engaged in development, manufacture ad sale of kits for genetic testing in routing diagnostic to laboratories. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The company has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The Company provides its products in more than 45 countries.
Employees
110
Date Price Change Volume
26-09-11 SEK 55.70 -1.94% 9,424
26-09-10 SEK 56.80 -3.40% 15,432
26-09-09 SEK 58.80 -2.00% 3,752
26-09-08 SEK 60.00 +0.67% 4,696
26-09-07 SEK 59.60 -0.50% 3,066
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
37.03DKK
Average target price
65.94DKK
Spread / Average Target
+78.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DVYSR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!